Carlos Iribarren

40.0k citations
227 papers · 13.0k indexed · 2 hit papers · h-index 63
Topics
Asthma and respiratory diseases (30 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers)Lipoproteins and Cardiovascular Health (24 papers)
Partner nations
United StatesSpainNorway

In The Last Decade

Carlos Iribarren

221 papers receiving 12.5k citations

Hit Papers

Body Mass Index and Risk for End-Stage Renal Disease2001202620092017200620012505007501000

Peers

Carlos Iribarren
Comparison fields: 5 of 183
  • Cardiology and Cardiovascular Medicine 3.2k
  • Pulmonary and Respiratory Medicine 3.0k
  • Physiology 2.7k
  • Nephrology 2.0k
  • Surgery 1.8k
Replace Johan Ärnlöv with:
Johan Ärnlöv Sweden
Jacqueline C.M. Witteman Netherlands
Rijk O. B. Gans Netherlands
Sun Ha Jee South Korea
Johan Sundström Sweden
Gorm Boje Jensen Denmark
Erik Ingelsson Sweden
Todd A. MacKenzie United States
Leopoldo Raij United States
Pamela L. Lutsey United States
Carlos Iribarren relative to Johan Ärnlöv Sweden Johan Ärnlöv's profile →
Citations per field
00.5×1.5×2.5×
Johan Ärnlöv · 1×
Citations per year

Countries citing papers authored by Carlos Iribarren

Since Specialization
Citations

This map shows the geographic impact of Carlos Iribarren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Iribarren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Iribarren more than expected).

Fields of papers citing papers by Carlos Iribarren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Iribarren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Iribarren. The network helps show where Carlos Iribarren may publish in the future.

Co-authorship network of co-authors of Carlos Iribarren

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Iribarren. A scholar is included among the top collaborators of Carlos Iribarren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Iribarren. Carlos Iribarren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 6
5 83
6 7
7 9
8 5
9 20
10 7
11 170
12 50
13 59
14 25
15
The metabolic syndrome is no better than its components.
6
16 122
17 28
18 269
19 36
20
Patterns of covariation of serum β-carotene and α-tocopherol in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
7

About Carlos Iribarren

Carlos Iribarren is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Physiology, having authored 227 papers that have together received 13.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (30 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers) and Lipoproteins and Cardiovascular Health (24 papers). The work is most often cited by research in Nephrology (2.0k citations), Cardiology and Cardiovascular Medicine (3.2k citations) and Physiology (2.7k citations). Carlos Iribarren has collaborated with scholars based in United States, Spain and Norway. Frequent co-authors include Alan S. Go, Jeanne Darbinian, Chi‐yuan Hsu, Charles E. McCulloch, Mark D. Eisner, Stephen Sidney, David R. Jacobs, Paul D. Blanc, Patricia Katz and Myron D. Gross. Their work appears in journals such as New England Journal of Medicine, JAMA and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026